..., instructions or products referred to in the content or advertisements. 2023 At present, there is limited literature evaluating Lp(a) levels and its association with coronary artery thrombosis in vivo [ 4 ]. In the setting of acute ST-segment elevation myocardial infarction (STEMI), plaque rupture...

... discontinuation of warfarin and introduction of rivaroxaban, developed thrombosis of his mechanical mitral prosthesis. Fig. 1. TTE with pulsed Doppler of the transprosthetic flow, showing an increase in the mean gradient and a decrease in the effective valve area. Fig. 1. TTE with pulsed Doppler...

... studies have shown post-closure sequelae, such as residual leakage, thrombosis with or without myocardial infarction, and coronary stenosis. Therefore, there has been a shift from intervention towards watchful waiting in asymptomatic patients. In this article, we review the published literature...

...Raban V. Jeger; Hans Peter Brunner-La Rocca; Osmund Bertel; Wolfgang Kiowski; Matthias E. Pfisterer; Christoph A. Kaiser; for the BASKET Investigators Objectives: To assess independent predictors of stent thrombosis (ST) in an all-comer trial. Methods: This is an observational case-control study...

...Parin J. Patel; William H. Matthai, Jr.; William J. Untereker Systemic lupus erythematosus is a chronic inflammatory disorder that predisposes to acute coronary thrombosis. To demonstrate how the pathophysiology of lupus-mediated coronary events may be unique, we offer the case and management...

...-T wave abnormalities. Angiographic data revealed a totally occluded right coronary artery at the level of the previously placed BMS, consistent with an acute occlusion and a significant thrombus. Our findings revealed that BMS thrombosis can occur as late as 10 years after implantation. Further data...

...(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Women Myocardial infarction Thrombosis Cardiology 1995:86:299-303 Richard C. Becker Thrombosis Research Center...

... and thrombosis have been recognized as playing central roles in cardiovascular morbidity and mortality. In order to provide a conceptual framework for the use of antithrombotic therapy, the pathogenetic mechanisms underlying thrombotic events must be clearly understood. The purpose of this review is to define...

... and circulating blood components provide the ideal environment for this fundamental, life-sustaining process. While hemostasis is a vital defense mechanism, preventing blood loss and ensuring rapid vessel repair, nonphysiologic thrombosis or ‘hemostasis in the wrong place’ may impair blood flow enough to cause...

... clinical outcome among patients sustaining acute myocardial infarction. 24 07 1991 8 08 1991 12 11 2008 Coronary Care Cardiology 1992;80:65-70 Richard C. Becker Jeanne M. Corrao Robert Lew James Bradley James Queenan Thrombosis Research Center. Division of Cardiology, Departments...

...Richard C. Becker In general terms, thrombotic disorders of the cardiovascular system are characterized by poorly regulated, nonphysiologic thrombus formation. Considered more specifically, however, pathologic thrombosis represents a critical imbalance, frequently at both the systemic and vascular...

.... Thrombosis Acute consumption coagulopathy Embolism 14 06 1985 16 01 1986 11 11 2008 Cardiology 74: 58-61 (198 7) ©1987 S. Karger AG. Basel 0008-6312 87 074I-O058S2.75 0 Intracardiac Thrombosis Associated with an Acute Consumption Coagulopathy J.P. Scu/iera , A. Counea , J.L...

... or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Saturated fat Cholesterol Fatty acids Thrombosis Coronary disease Cardiology 74: 22-27 (1987) Dietary Fat and Coronary Heart Disease: There Is Much More to Learn M.F. Oliver...

... After 8 weeks of this treatment the animals underwent the venous prethrombotic model before being killed. Blood samples and heart tissues were collected for hematocrit assay, MI size and area at risk (AAR) measurements. Erythropoietin Cardioprotection Myocardial infarction Thrombosis...

... Stents Survival Thrombosis Interventional revascularization therapy after coronary artery bypass graft (CABG) surgery needs to be performed in 1–2% of patients per year within the first 5 years after surgery and in 4% per year subsequently [ 1 ]. While atherosclerotic changes leading to severe...

...Mohammad Bagher Sharifkazemi; Mahmood Zamirian; Amir Aslani Discontinuation of antiplatelet medications has been strongly associated with coronary stent thrombosis. The first reported cases have been documented at 6 h to 6 weeks after stent implantation. This article presents a case of very late...

... by thrombosis or fibro-intimal hyperplasia superimposed by thrombosis, our finding also implies an association of MBL deficiency with thrombotic events. It remains unclear whether the previously confirmed effect of MBL deficiency in coronary disease is mediated through this possible thrombotic mechanism...

...Khalid Barakat; Nicholas M. Robinson; Rowarth A.J. Spurrell Although transvenous pacing is a safe treatment modality for bradyarrhythmias, serious thrombotic and embolic complications are reported to occur in 0.6–3.5% of cases. We describe 5 cases of pacemaker-associated thrombosis, 3...

...Michael Shechter; C. Noel Bairey Merz; Maura J. Paul-Labrador; Prediman K. Shah; Sanjay Kaul Elevated plasma apolipoprotein B is a known risk factor for atherosclerotic coronary artery disease (CAD), however its relationship to arterial thrombosis is unexplored. We prospectively assessed...

... risk factor for subacute stent thrombosis and that this potentially catastrophic event may occur late after implantation. Potential implications for revascularization strategies and medical treatment are discussed. 22 3 1999 1999 Copyright / Drug Dosage / Disclaimer Copyright: All...